Safety study of HW252001 in healthy volunteers
Part of Lungs & breathing clinical trials.
This is a first-in-human study of an investigational drug called HW252001. Healthy volunteers will receive a single dose to see how safe it is and how the body processes it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy adult between 18 and 55 years old.
- You weigh at least 100 pounds if female, or 110 pounds if male, with a BMI between 19 and 26.
- You have no history of cancer (except certain treated skin or cervical cancers or colon polyps).
- You do not smoke more than 5 cigarettes a day and are willing to stop smoking during the study.
- You do not drink more than about 1 beer or glass of wine daily and are willing to avoid alcohol.
- You have no major illnesses, drug abuse, or allergies to the study medication.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the safety of a new drug called HW241045 in healthy volunteers. It helps doctors understand how the drug affects the body and if it causes any side effects.
This is an early-stage safety study testing a new inhaled medication called RC010 in healthy volunteers. Researchers want to understand how safe it is, how well people tolerate it, and how the body processes it.
This is an early-stage safety and tolerability study of a new drug called HW241045 in healthy volunteers. Researchers will test the drug at different doses to understand how the body processes it and what side effects it may cause.
This trial tests a new drug called HW243040 in healthy adults to see how safe it is. It helps researchers understand how the drug works in the body before testing it in patients with a condition.
This early-stage study tests a new investigational drug called HW201877 in healthy volunteers. The goal is to see if the drug is safe and how the body processes it.
This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.
Hear when a new IPF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.